Breaking News on Global Pharmaceutical Technology & Manufacturing

Regulatory & Safety: Top Headlines


NHS rejects suggestion a lack of guidance has slowed biosimilar uptake

NHS cites guidance doc in light of criticism

06-Oct-2015 - The NHS has rejected Napp Pharmaceuticals’ accusation it lacks biosimilar guidance, citing a recently published policy document.

Related news

News in brief

US FDA issues alert for sterile products made by Californian compounder

06-Oct-2015 - The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.


UK and India sign agreement to help ensure drug quality

05-Oct-2015 - The MHRA has signed a Memorandum of Understanding (MOU) with Indian regulators to help ensure the quality of drugs in the UK.

Round 2 Amgen? US FDA accepts Sandoz's Enbrel biosimilar for review

02-Oct-2015 - A second Sandoz biosimilar has been accepted for review by US FDA setting the stage for another potential legal battle with Amgen.

Very unscientific survey

Android or iOS: Which cell phone OS does the drug industry prefer?

01-Oct-2015 - Do API firms adore android? Do ocular drug developers’ eyes light up when they think of iOS? 

US FDA rule: banned drugs will be destroyed

30-Sep-2015 - The FDA will begin destroying drugs which are refused entry to the US instead of returning them to their sender.


FDA announces Quality head

29-Sep-2015 - Plus PhRMA appoints chief executive, and more people news in this week's gallery.

Polpharma hires ex Lupin, Teva and Merck KGaA man to lead biosimilar push

29-Sep-2015 - Polpharma has continued its biosimilar-focused hiring spree and appointed Maurice Chagnaud as its CEO.

Regulatory & Safety: Featured news

Key Industry Events


Access all events listing

Our events, Shows & Conferences...